Impax Opens New Front In Adderall Battle With Shire
California-based Impax is seeking a declaratory judgment that it does not infringe Maryland-based Shire’s Adderall patent and that the patent’s claims are invalid. The suit was filed in the U.S. District Court for the District of Delaware.
Shire sued Impax, as well as Barr Laboratories Inc.,...
To view the full article, register now.